carboxypolymethylene has been researched along with Orthomyxoviridae Infections in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baart, M; Carrow, EW; Gartlan, KH; Moghaddam, AE; Powell, TJ; Russell, RA; Sattentau, QJ; Schiffner, T; Wegmann, F | 1 |
Carrow, E; Gasper, DJ; Imai, H; Kawaoka, Y; Neldner, B; Plisch, EH; Rustom, H; Suresh, M | 1 |
Baumgarte, S; Dürrwald, R; Krumbholz, A; Schlegel, M; Selbitz, HJ; Vahlenkamp, TW; Wutzler, P; Zell, R | 1 |
3 other study(ies) available for carboxypolymethylene and Orthomyxoviridae Infections
Article | Year |
---|---|
The Carbomer-Lecithin Adjuvant Adjuplex Has Potent Immunoactivating Properties and Elicits Protective Adaptive Immunity against Influenza Virus Challenge in Mice.
Topics: Acrylic Resins; Adaptive Immunity; Adjuvants, Immunologic; Animals; Antibodies, Viral; B-Lymphocytes; CD8-Positive T-Lymphocytes; Cytokines; Dendritic Cells; Hemagglutinin Glycoproteins, Influenza Virus; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Lecithins; Mice, Inbred BALB C; Orthomyxoviridae Infections; Pathogen-Associated Molecular Pattern Molecules; Th1-Th2 Balance; Vaccination | 2015 |
Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines.
Topics: Acrylic Resins; Adjuvants, Immunologic; Administration, Intranasal; Adoptive Transfer; Animals; CD8-Positive T-Lymphocytes; Disease Models, Animal; Flow Cytometry; Influenza A virus; Influenza Vaccines; Lecithins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Orthomyxoviridae Infections; Respiratory Tract Infections; T-Lymphocytes, Cytotoxic | 2016 |
Swine influenza A vaccines, pandemic (H1N1) 2009 virus, and cross-reactivity.
Topics: Acrylic Resins; Adjuvants, Immunologic; Animals; Antibodies, Viral; Antibody Specificity; Disease Outbreaks; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H1N2 Subtype; Influenza A Virus, H3N2 Subtype; Influenza Vaccines; Mineral Oil; Neutralization Tests; Orthomyxoviridae Infections; Swine; Treatment Outcome | 2010 |